Literature DB >> 29402414

CaMKII-mediated phosphorylation of RyR2 plays a crucial role in aberrant Ca2+ release as an arrhythmogenic substrate in cardiac troponin T-related familial hypertrophic cardiomyopathy.

Shinichi Okuda1, Yoko Sufu-Shimizu2, Takayoshi Kato2, Masakazu Fukuda2, Shigehiko Nishimura2, Tetsuro Oda2, Shigeki Kobayashi2, Takeshi Yamamoto3, Sachio Morimoto4, Masafumi Yano2.   

Abstract

AIMS: Cardiac Troponin T (TnT) mutation-linked familial hypertrophic cardiomyopathy (FHC) is known to cause sudden cardiac death at a young age. Here, we investigated the role of the Ca2+ release channel of the cardiac sarcoplasmic reticulum (SR), ryanodine receptor (RyR2), in the pathogenic mechanism of lethal arrhythmia in FHC-related TnT-mutated transgenic mice (TG; TnT-delta160E). METHODS AND
RESULTS: In TG cardiomyocytes, the Ca2+ spark frequency (SpF) was much higher than that in non-TG cardiomyocytes. These differences were more pronounced in the presence of isoproterenol (ISO; 10 nM). This increase in SpF was largely reversed by a CaMKII inhibitor (KN-93), but not by a protein kinase A inhibitor (H89). CaMKII phosphorylation at Ser2814 in RyR2 was increased significantly in TG. Spontaneous Ca2+ transients (sCaTs) after cessation of a 1-5 Hz pacing, frequently observed in ISO-treated TG cardiomyocytes, were also attenuated by KN-93, but not by H89. The RyR2 stabilizer dantrolene attenuated Ca2+ sparks and sCaTs in ISO-treated TG cardiomyocytes, indicating that the mutation-linked aberrant Ca2+ release is mediated by destabilized RyR2.
CONCLUSIONS: In FHC-linked TnT-mutated hearts, RyR2 is susceptible to CaMKII-mediated phosphorylation, presumably because of a mutation-linked increase in diastolic [Ca2+]i, causing aberrant Ca2+ release leading to lethal arrhythmia.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ca(2+)/calmodulin dependent kinase II; Familial hypertrophic cardiomyopathy; Ryanodine receptor type 2; Troponin T

Mesh:

Substances:

Year:  2018        PMID: 29402414     DOI: 10.1016/j.bbrc.2018.01.181

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Role of circular RNAs in cardiovascular diseases.

Authors:  Xue Gong; Gengze Wu; Chunyu Zeng
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-17

2.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

3.  Enhanced NCLX-dependent mitochondrial Ca2+ efflux attenuates pathological remodeling in heart failure.

Authors:  Joanne F Garbincius; Timothy S Luongo; Pooja Jadiya; Alycia N Hildebrand; Devin W Kolmetzky; Adam S Mangold; Rajika Roy; Jessica Ibetti; Mary Nwokedi; Walter J Koch; John W Elrod
Journal:  J Mol Cell Cardiol       Date:  2022-03-28       Impact factor: 5.763

4.  Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.

Authors:  Carlos A Valverde; Gabriela Mazzocchi; Mariano N Di Carlo; Alejandro Ciocci Pardo; Nehuen Salas; María Ines Ragone; Juan I Felice; Alejandra Cely-Ortiz; Alicia E Consolini; Enrique Portiansky; Susana Mosca; Evangelia G Kranias; Xander H T Wehrens; Alicia Mattiazzi
Journal:  Cardiovasc Res       Date:  2019-03-01       Impact factor: 10.787

Review 5.  Evaluation of cardiac hypertrophy in the setting of sudden cardiac death.

Authors:  Kristopher S Cunningham; Danna A Spears; Melanie Care
Journal:  Forensic Sci Res       Date:  2019-08-19

6.  Magnesium Ions Moderate Calcium-Induced Calcium Release in Cardiac Calcium Release Sites by Binding to Ryanodine Receptor Activation and Inhibition Sites.

Authors:  Bogdan Iaparov; Iuliia Baglaeva; Ivan Zahradník; Alexandra Zahradníková
Journal:  Front Physiol       Date:  2022-01-25       Impact factor: 4.566

7.  Susceptibility Modules and Genes in Hypertrophic Cardiomyopathy by WGCNA and ceRNA Network Analysis.

Authors:  Yifan Sun; Zhongbo Xiao; Yequn Chen; Duanmin Xu; Shuying Chen
Journal:  Front Cell Dev Biol       Date:  2022-02-01

8.  Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits.

Authors:  James G W Smith; Thomas Owen; Jamie R Bhagwan; Diogo Mosqueira; Elizabeth Scott; Ingra Mannhardt; Asha Patel; Roberto Barriales-Villa; Lorenzo Monserrat; Arne Hansen; Thomas Eschenhagen; Sian E Harding; Steve Marston; Chris Denning
Journal:  Stem Cell Reports       Date:  2018-11-01       Impact factor: 7.765

9.  Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease.

Authors:  Haikel Dridi; Xiaoping Liu; Qi Yuan; Steve Reiken; Mohamad Yehia; Leah Sittenfeld; Panagiota Apostolou; Julie Buron; Pierre Sicard; Stefan Matecki; Jérome Thireau; Clement Menuet; Alain Lacampagne; Andrew R Marks
Journal:  JCI Insight       Date:  2020-10-02

10.  Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics.

Authors:  Jamie R Bhagwan; Diogo Mosqueira; Karolina Chairez-Cantu; Ingra Mannhardt; Sara E Bodbin; Mine Bakar; James G W Smith; Chris Denning
Journal:  J Mol Cell Cardiol       Date:  2020-06-10       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.